<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal Cancer
Matthias Ebert(University of Mannheim), Roland M. Schmid(Tumkur University), Tibor Schuster(Technical University of Munich), Christoph Röcken(University Hospital Schleswig-Holstein), Karsten Schulmann(Klinikum Arnsberg), Philipp Ströbel(Universitätsmedizin Göttingen), Anke Reinacher‐Schick(Ruhr University Bochum), Rainer Porschen(Klinikum Bremen-Mitte), David J. Hughes(University College Dublin), Ralf‐Dieter Hofheinz(University of Mannheim), Jan Stöhlmacher-Williams(Technische Universität Dresden), Elke Burgermeister(Heidelberg University), Andrea Tannapfel(Leipzig University), Marc Tänzer(Heidelberg University), Robert Rosenberg(Kantonsspital Baselland), Reimo Tetzner(Epigenomics (Germany)), Gisela Keller(Technical University of Munich), Rupert Langer(Johannes Kepler University of Linz), Katja Specht(Technical University of Munich), Catherine Lofton–Day(Seattle University), A. Kretzschmar(University Hospital Leipzig), Benjamin Balluff(Maastricht University)
Cited by 184
Related Papers
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k